Envestnet Asset Management Inc. Reduces Stake in Halozyme Therapeutics, Inc. $HALO
Envestnet Asset Management Inc. lowered its position in Halozyme Therapeutics, Inc. (NASDAQ:HALO - Free Report) by 11.2% in the 2nd quarter, according to its most recent disclosure with the...